|
Video: What is a Stock Split?
|
|
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for cancer. Co. utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies (ETBs). ETBs use a genetically engineered version of the Shiga-like Toxin A subunit (SLTA), a ribosome inactivating bacterial protein. In its wild-type form, SLT is thought to induce its own entry into a cell when proximal to the cell surface membrane, self-route to the cytosol, and enzymatically and irreversibly shut down protein synthesis via ribosome inactivation. Co. has developed ETBs to various targets, including PD-L1, CD38, and CTLA-4. According to our MTEM split history records, Molecular Templates has had 1 split. | |
|
Molecular Templates (MTEM) has 1 split in our MTEM split history database. The split for MTEM took place on August 02, 2017. This was a 1 for 11 reverse split, meaning for each 11 shares of MTEM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 90.9090909090909 share position following the split.
When a company such as Molecular Templates conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the MTEM split history from start to finish, an original position size of 1000 shares would have turned into 90.9090909090909 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Molecular Templates shares, starting with a $10,000 purchase of MTEM, presented on a split-history-adjusted basis factoring in the complete MTEM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$52.36 |
|
End price/share: |
$2.36 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.49% |
|
Average Annual Total Return: |
-26.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$450.59 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
08/02/2017 | 1 for 11 |
|
|